Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice
- 1 September 2005
- journal article
- Published by Elsevier BV in Journal of Bioscience and Bioengineering
- Vol. 100 (3), 280-287
- https://doi.org/10.1263/jbb.100.280
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 20 references indexed in Scilit:
- Dynamics of success and failure in phage and antibiotic therapy in experimental infectionsBMC Microbiology, 2002
- The use of bacteriophages for treatment and prevention of bacterial disease in animals and animal models of human infectionJournal of Chemical Technology & Biotechnology, 2001
- Isolation and characterization ofEscherichia coliO157 from retail beef and bovine feces in ThailandFEMS Microbiology Letters, 2000
- Construction of mini-Tn10luxABcam/Ptac-ATS and its use for developing a bacteriophage that transduces bioluminescence toEscherichia coliO157:H7FEMS Microbiology Letters, 2000
- Bacteriophages show promise as antimicrobial agentsJournal of Infection, 1998
- EFFECT OF RESOURCE ENRICHMENT ON A CHEMOSTAT COMMUNITY OF BACTERIA AND BACTERIOPHAGEEcology, 1997
- Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin IInfection, 1992
- Shiga Toxin: Biochemistry, Genetics, Mode of Action, and Role in PathogenesisCurrent Topics in Microbiology and Immunology, 1992
- A Preliminary Report on the Use of Staphage Lysate for Treatment of Hidradenitis SuppurativaAnnals of Plastic Surgery, 1981
- Resource-Limited Growth, Competition, and Predation: A Model and Experimental Studies with Bacteria and BacteriophageThe American Naturalist, 1977